| Emerging therapeutic agents for advanced non-small cell lung cancer R Chen, R Manochakian, L James, AG Azzouqa, H Shi, Y Zhang, Y Zhao, ... Journal of hematology & oncology 13, 1-23, 2020 | 260 | 2020 |
| Sex differences in tolerability to anti‐programmed cell death protein 1 therapy in patients with metastatic melanoma and non‐small cell lung cancer: are we all equal? N Duma, A Abdel‐Ghani, S Yadav, KP Hoversten, CT Reed, AN Sitek, ... The oncologist 24 (11), e1148-e1155, 2019 | 102 | 2019 |
| Reducing unplanned medical oncology readmissions by improving outpatient care transitions: a process improvement project at the Cleveland Clinic AJ Montero, J Stevenson, AE Guthrie, C Best, LM Goodman, S Shrotriya, ... Journal of oncology practice 12 (5), e594-e602, 2016 | 59 | 2016 |
| Survival trends in young patients with multiple myeloma: a focus on racial-ethnic minorities S Ailawadhi, AG Azzouqa, D Hodge, J Cochuyt, P Jani, S Ahmed, T Sher, ... Clinical Lymphoma Myeloma and Leukemia 19 (10), 619-623, 2019 | 19 | 2019 |
| The evolution of the diminishing role of extrapleural pneumonectomy in the surgical management of malignant pleural mesothelioma AG Azzouqa, JP Stevenson OncoTargets and therapy, 7247-7252, 2016 | 11 | 2016 |
| Reduction of inappropriate prophylactic pegylated granulocyte colony-stimulating factor use for patients with non–small-cell lung cancer who receive chemotherapy: an ASCO … L Martin Goodman, MB Moeller, AG Azzouqa, AE Guthrie, CK Dalby, ... Journal of Oncology Practice 12 (1), e101-e107, 2016 | 10 | 2016 |
| Impact of good and poor mobilizers on hematopoietic progenitor cell collection efficiency and product quality AGM Azzouqa, K Jouni, V Roy, AC Zubair Journal of Clinical Apheresis 34 (1), 39-43, 2019 | 8 | 2019 |
| Association of CDKN2A gene alteration with high expression of PD-L1. Y Zhang, JA Marin-Acevedo, AG Azzouqa, R Manochakian, Y Lou Journal of Clinical Oncology 36 (15_suppl), 9102-9102, 2018 | 8 | 2018 |
| Impact of time to treatment initiation (TTI) on survival of patients with newly diagnosed non-small cell lung cancer (NSCLC). AG Azzouqa, R Chen, Y Lou, S Ailawadhi, R Manochakian Journal of Clinical Oncology 37 (15_suppl), 9058-9058, 2019 | 5 | 2019 |
| Monoclonal antibody utilization characteristics in patients with multiple myeloma S Ailawadhi, T Sher, AG Azzouqa, Z Meghji, T Jain, P Jani, S Ahmed, ... Anti-cancer drugs 30 (8), 859-865, 2019 | 3 | 2019 |
| Myelodysplasia-related acute myeloid leukemia and acute promyelocytic leukemia: Concomitant occurrence of two molecularly distinct diseases YAM Vanegas, AGM Azzouqa, DM Menke, JM Foran, P Vishnu Hematology Reports 10 (3), 7658, 2018 | 3 | 2018 |
| Immune-related adverse events: Comparison of melanoma and non-small cell lung cancer patients treated with anti-PD1 therapy N Duma, AG Azzouqa, S Yadav, K Hoversten, C Reed, AN Sitek, Y Lou, ... Annals of Oncology 29, viii432, 2018 | 2 | 2018 |
| Correlation of survival outcomes with clinical and molecular features in lung cancer patients treated with immune checkpoint inhibitors R Chen, AG Azzouqa, Y Zhang, JA Marin-Acevedo, R Manochakian, ... International Journal of Radiation Oncology, Biology, Physics 104 (1), 232, 2019 | 1 | 2019 |
| Decreased physical activity in autologous stem cell recipients leads to reduced QOL scores during hospitalization C Baldeo, YM Vanegas, S Khurana, M Iqbal, AG Azzouqa, T Sher, ... Blood 132, 5895, 2018 | 1 | 2018 |
| Effect of improving guideline-based prophylactic growth factor (pGCSF) use with chemotherapy (CT) on the risk of febrile neutropenia (FN) in non-small cell lung cancer (NSCLC … LM Goodman, M Moeller, CK Dalby, A Azzouqa, AE Guthrie, MA Earl, ... Journal of Clinical Oncology 33 (15_suppl), 6565-6565, 2015 | 1 | 2015 |
| Efficacy of gemcitabine in combination with nanoparticle a lbumin‐bound paclitaxel in the treatment of recurrent ovarian cancer: A retrospective single institution review AM Kase, AG Azzouqa, S Kochuveettil, G Colon‐Otero Cancer medicine 12 (8), 9434-9438, 2023 | | 2023 |
| Abstract A120: Sex differences in tolerability and response to immune checkpoint inhibitors in non-small cell lung cancer patients N Duma, AG Azzouqa, S Yadav, K Hoversten, C Reed, A Sitek, E Enninga, ... Cancer Epidemiology, Biomarkers & Prevention 29 (6_Supplement_1), A120-A120, 2020 | | 2020 |
| 603 Testicular Myeloid Sarcoma: A Systematic Review of the Literature KK Sahu, AA Sherif, AK Mishra, A Lal, A Singh, S Ailawadhi, AG Azzouqa, ... | | 2019 |
| P1. 12-08 The Impact of Patient Age and Socioeconomic Factors on Clinical Outcomes in Small Cell Lung Cancer (SCLC): A National Study R Chen, A Azzouqa, R Manochakian, S Ailawadhi, Y Lou Journal of Thoracic Oncology 14 (10), S537, 2019 | | 2019 |
| Combination of gemcitabine and nab-paclitaxel is active against recurrent ovarian cancer: Single institution retrospective review AGM Azzouqa, G Colon-Otero Gynecologic Oncology 154, 215-216, 2019 | | 2019 |
